Product launch for new dosage strength of an existing product within the SNRI generic market
The program was well received by the target HCPs and their practice. Prior to the conclusion of the original 6 monthprogram, client extended the contract by 6 months along with adding addition resources to the program to increase the reach and frequency. At the conclusion of the total 12 months, the growth of the product encouraged client to continue for an additional year. The program concluded with a 5-1 ROI.